Amin Pasha, MD
Critical Care Medicine · Detroit, MINPI 1861760050
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 354 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Among critical care medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $22.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$1K
- AstraZeneca$1K
- GSK$768
- Boehringer Ingelheim$695
- Actelion Pharmaceuticals US, Inc.$585
- Sanofi$536
- plus $3K from 33 others
What the payments were for
- Food & beverage$7,87098%
- Education$1892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 42 | $1,051 |
| AstraZeneca | 49 | $1,009 |
| GSK | 58 | $768 |
| Boehringer Ingelheim | 25 | $695 |
| Actelion Pharmaceuticals US, Inc. | 20 | $585 |
| Sanofi | 14 | $536 |
| Pulmonx Corporation | 14 | $382 |
| Regeneron Healthcare Solutions, Inc. | 13 | $350 |
| Grifols USA, LLC | 12 | $290 |
| Electromed, Inc. | 22 | $269 |
| Sunovion Pharmaceuticals Inc. | 17 | $232 |
| Inspire Medical Systems, Inc. | 3 | $231 |
| Johnson & Johnson | 6 | $228 |
| Verona Pharma, Inc. | 12 | $147 |
| Mallinckrodt Enterprises LLC | 3 | $126 |
| Mylan Specialty L.p. | 5 | $111 |
| Bard Access Systems, Inc. | 2 | $102 |
| Bayer | 4 | $93 |
| Viatris Specialty LLC | 3 | $87 |
| Inari Medical, Inc. | 1 | $87 |
| Jazz Pharmaceuticals Inc. | 4 | $67 |
| Sanofi-aventis U.S. LLC | 1 | $62 |
| Intuitive Surgical | 1 | $58 |
| Insmed, Inc. | 3 | $56 |
| Resmed Corp | 2 | $54 |
| Teleflex LLC | 1 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Lungpacer Medical USA Inc | 1 | $40 |
| Circassia Inc. | 3 | $38 |
| Merck | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| CSL Behring | 1 | $28 |
| Edwards Lifesciences | 1 | $23 |
| Harmony Biosciences LLC | 1 | $22 |
| Gilead | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Advanced Respiratory, Inc | 1 | $13 |
| Veran Medical Technologies, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$275
- Inspire$147
- XARELTO$125
- UPTRAVI$125
- CHARTIS CATHETER$112
- ZEPHYR DELIVERY CATHETER$112
- ZEPHYR ENDOBRONCHIAL VALVE$112
- PULMONX CHARTIS TABLET CONSOLE$112
How this compares
$8,059 in reported general payments places this provider in the 90th percentile of 177 critical care medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 85 | $71,406 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 46 | $33,574 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 22 | $11,829 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $2,628 |
| Fluticasone Propionate | 22 | $398 |
| Montelukast Sodium | 21 | $311 |
| Prednisone | 39 | $153 |
| Azithromycin | 18 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $768 | $83,235107 claims |
| AstraZenecaBreztri Aerosphere | $1,009 | $33,57446 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 177 critical care medicine providers in Michigan.
Other critical care medicine in Detroit
- Angel Peralta-AvilaDetroit$147K
- Xavier Fonseca FuentesDetroit$4K
- Domingo Franco PalaciosDetroit$2K
- William PeruzziDetroit$2K
- Mhd Hussam Al JandaliDetroit$1K
- Sai KattaDetroit$1K
- Christine AchoDetroit$918
- Moumen AsbahiTroy$81K
- Mujahed AbbasLansing$28K
- Abdulrazak AlchakakiSouthfield$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.